Acute leukemia in childhood: Classification, diagnosis, therapy and prognosis;Akute Leukamien im Kindesalter. Klassifikation, Diagnose, Therapie, Prognose

Internist

Volumn 37, Issue 10, 1996, Pages 982-993

  Creutzig, Ursula ^a,c   Schrappe, M ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BONE MARROW TRANSPLANTATION; CANCER CLASSIFICATION; CHILDHOOD LEUKEMIA; HUMAN; INTRATHECAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PROGNOSIS; REVIEW; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; CHILD; CLASSIFICATION; INFANT; PRESCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; PROGNOSIS;

EID: 0029806266     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van't Veer MB (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 9: 1783-1786
2. Harbott J, Ritterbach J, Ludwig WD, Bartram CR, Reiter A, Lampert F (1993) Clinical significance of cytogenetic studies in childhood acute lymphoblastic leukemia: experience of the BFM trials. Recent Results Cancer Res 131: 123-132
3. Yokota S, Hansen Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, Bartram CR (1991) Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 77: 331-339
4. Machnicki JL, Bloomfield CD (1990) Clinical significance of the cytogenetics of acute leukemias. Oncol 4: 23-30
5. Hiddemann W, Harbott J, Ludwig WD, Ritter J, Nehmer A, Reiter A, Kolkmeyer A, Laing T, Riehm H (1993) DNA aneuploidy in childhood acute lymphoblastic leukemia: relation to clinical determinants and prognosis within four consecutive BFM trials. Recent Results Cancer Res 131: 113-121
6. Tubergen DG, Gilchrist GS, O'Brien RT, Coccia PF, Sather HN, Waskerwitz MJ, Hammond GD (1993) Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial. J Clin Oncol 11: 527-537
7. Gaynon PS, Steinherz PG, Bleyer WA, Ablin AR, Albo VC, Finklestein JZ, Grossman NJ, Novak LJ, Pyesmany AF, Reaman GH, et al. (1993) Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group study CCG-106. J Clin Oncol 11: 2234-2242
8. Janka-Schaub GE, Stührk H, Kortüm B, Graubner U, Haas RJ, Göbel U, Jürgens H, Spaar HJ, Winkler K (1992) Bone-marrow blast count at day 28 as the single-most important prognostic factor in childhood acute lymphoblastic leukemia. Hematol Bluttransfus 34: 233-237
9. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampen F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 84: 3122-3133
10. Rivera GK, Raimondi SC, Hancock ML, Behm FG, Pui CH, Abromowitch M, Mirro J Jr., Ochs JS, Look AT, Williams DL (1991) Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 337(8733):61-66
11. Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE (1994) Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Caner Institute/ Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. J Clin Oncol 12: 740-747
12. Schrappe M, Reiter A, Sauter S, Ludwig WD, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E, Havers W, Henze G, Kühl J, Ritter J, Treuner J, Zintl F, Odenwald E, Welte K, Riehm H (1994) Konzeption und Zwischenergebnis der Theapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: Die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark. Klin Pädiatr 206: 208-221
13. Reiter A, Schrappe M, Ludwig WD, Lampert F, Harbott J, Henze G, Niemeyer CM, Gadner H, Müller-Weihrich S, Ritter J, Odenwald E, Riehm H (1992) Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 80: 2471-2478
14. Burchenal JH, Murphy ML (1965) Long-term survivors in acute leukemia. Cancer Res 25: 1491-1494
15. Pinkel D (1979) Treatment of childhood acute lymphocytic leukemia. Hamatol Bluttransfus 23: 25-33
16. Riehm H, Gadner H, Henze G, Langermann H-J, Odenwald E (1980) The Berlin childhood acute lymphoblastic leukemia therapy study, 1970-1976. Am J Pediatr Hematol Oncol 2: 299-306
17. Riehm H, Gadner H, Henze G, Kornhuber B, Lumpert F, Niethammer D, Reiter A, Schellong G (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. Haematol Blood Transfus 33: 439-450
18. Pui CH (1995) Childhood leukemias. N Engl J Med 332: 1618-1630
19. Woods WG, Kobrinsky N, Buckley J, Neudorf S, Sanders J, Miller L, Barnard D, Benjamin D, DeSwarte J, Kalousek D, Shina D, Hammond GD, Lange BJ (1993) Intensively timed induction therapy followed by autologous or allogeneic hone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: A Childrens Cancer Group Pilot study. J Clin Oncol 11: 1448-1457
20. Ravindranath Y, Yeager AM, Chang MN, Steuber CP, Krischer J, Pole JG, Carroll A, Inoue S, Camitta B, Weinstein H (1996) Autologous hone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. N Engl J Med 334: 1428-1434
21. Creutzig U, Ritter J, Schellong G (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in the study AML-BFM-83 as compared with study AML-BFM-78. Blood 75: 1932-1940
22. Ravindranath Y, Steuber CP, Krischer J, Civin CI, Cucore J, Vega R, Pitel P, Inoue S, Bleher E, Sexauer C, Hutter J, Vietti T (1991) High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: A Pediatric Oncology Group study. J Clin Oncol 9: 572-850
23. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, McIntyre OR, Frei III E (1994) Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331: 896-903
24. Wells RJ, Woods WG, Buckley JD, Odom LF, Benjamin D, Bernstein I, Betcher D, Feig S, Kim T, Ruymann F, Smithson W, Srivastava A, Tannous R, Buckley CM, Whitt JK, Wolff L, Lampkin BC (1994) Treatment of newly diagnosed children and adolescents with acute myeloid leukemia: A Childrens Cancer Group study. J Clin Oncol 12: 2367-2377
25. Creutzig U, Ritter J, Zimmermann M, Schellong G, for the AML-BFM Study Group (1993) Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia (AML): unexpected results of the childhood AML Study BFM-87. J Clin Oncol 11: 279-286
26. Liesner RJ, Leiper AD, Hann IM, Chessells JM (1994) Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood. J Clin Oncol 12: 916-924
27. Creutzig U, Ritter J, Zimmermann M, Bender Götze C, Schellong G (1995) Bone-marrow transplantation [letter]. Lancet 346(8966):60
28. Woods WG, Kobrinsky N, Buckley JD, Lee JW, Sanders J, Neudorf S, Gold S, Barnard DR, DeSwarte J, Kalousek D, Arthur DC, Lange BJ (1996) Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Study Group. Blood 87: 4979-4989
29. Lie SO (1991) Acute myelogenous leukaemia in children. Eur J Pediatr 148: 382-388
30. Bührer C, Hartmann R, Fengler R, Dopfer R, Gadner H, Gerein V, Göbel U, Reiter A, Ritter J, Henze G (1993) Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 21: 470-476
31. Henze G, Fengler R, Hartmann R, Kornhuber B, Janka Schaub G, Niethammer D, Riehm H (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 78: 1166-1172
32. Borgmann A, Hartmann R, Schmid H, Klingebiel T, Ebell W, Göbel U, Peters C, Gadner H, Henze G (1995) Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Bone Marrow Transplant 15: 515-521
33. Kaatsch P, Michaelis J (1995) Zweitmalignome nach malignen Erkrankungen im Kindesalter. Klin Pädiatr 207: 158-163
34. Brouwers P, Poplack D (1990) Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: Association with attention deficits. Am J Pediatr Hematol Oncol 12: 174-181
35. Green DM, Hall B, Zevon MA (1989) Pregnancy outcome after treatment for acute lymphoblastic leukemia during childhood or adolescence. Cancer 64: 2335-2339
36. Lipshultz SE, Colan SD, Gelber RD, Perez-Atayde AR, Sallan S, Sanders SP (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324: 808-815
37. van der Does van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Debatin KM, Haas OA, Harbott J, Kamps WA, Köller U, et al. (1992) Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group. Med Pediatr Oncol 20: 497-505
38. Ludwig WD, Harbott J, Bartram CR, Komischke B, Sperling C, Teichmann JV, Seibt Jung H, Notter M, Odenwald E, Nehmer A, et al. (1993) Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86. Recent Results Cancer Res 131: 269-282
39. Creutzig U, Harbott J, Sperling C, Ritter J, Zimmermann M, Löffler M, Riehm HJ, Ludwig W-D (1995) Clinical significance of surface antigen expression in children with acute myeloid leukemia: Results of Study AML-BFM-87. Blood 86: 3097-3108
40. Nesbit ME, Buckley JD, Feig SA, Anderson JR, Lampkin B, Bernstein ID, Kim TH, Piomelli S, Kersey JH, Coccia PF, O'Reilly RC, August C, Thomas ED, Hammond GD (1994) Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy - A report from the Children's Cancer Group. J Clin Oncol 12: 127-135
41. Amadori S, Testi AM, Aricò M, Comelli A, Giuliano M, Madon E, Masera G, Rondelli R, Zanesco L, Mandelli F, for the Associazione Italiana Ematologia ed Oncologia Pediatrica Cooperative Group (1993) Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. J Clin Oncol 11: 1046-1054